Email Alert | RSS

Journal of Tuberculosis and Lung Health ›› 2014, Vol. 3 ›› Issue (4): 257-260.doi: 10.3969/j.issn.2095-3755.2014.04.010

Previous Articles     Next Articles

Effect analysis of compensation policy on TB auxiliary drug included in new rural cooperative medical scheme in Xinmi city

DUAN Hai-xia*, HE Bao-an, JIN Xiao-wei, GANG Zhu-feng, WEI Xiao-hui, JIN Hong-jian, HE Shi-de, LIU Yuan-sen   

  1. *Xinmi City Tuberculosis Prevention and Control Institute, Xinmi City of He’nan Province, Xinmi 452370,China
  • Received:2014-09-16 Online:2014-06-30 Published:2014-06-30
  • Contact: JIN Hong-jian, Email:xmjfs18@126.com

Abstract: Objective To explore the compensation policy effect of TB auxiliary drug included in new rural cooperative medical scheme(NCMS) in Xinmi city.Methods In addition to the free policy, since June 1, 2008, NCMS compensated 40% (increased to 60% in 2011, to 70% in 2014)of the TB auxiliary drugs for pulmonary tuberculosis patients participating the NCMS(From Jun.2008 to Jun.2014, a total of 3326 patients participated the NCMS).The annually supreme compensation limits per person was 600 Yuan (increased to 1200 Yuan in 2011, increased to 2000 Yuan in 2014).Results After 6 years of implementation, the compensation policy has reimbursed a total of 1 865 461.50 Yuan RMB for 3018 cases of tuberculosis patients participated in NCMS, with an average of 618.11 Yuan per patient. The per capita amount of compensation increases with the proportion of total amount to be reimbursed and the capping lines, the number of people received compensation accounted for 90.7%(3018/3326)of tuberculosis patients participating NCSM. Another 9.3% of tuberculosis patients did not receive the compensation due to no complications and no need for auxiliary drug.Conclusion The compensation method for TB auxiliary drug is appropriate, and achieved obvious effect.